Amlodipine Besylate; Hydrochlorothiazide; Valsartan Patent Expiration
Amlodipine Besylate; Hydrochlorothiazide; Valsartan is Used for treating high blood pressure. It was first introduced by Novartis Pharmaceuticals Corp
Amlodipine Besylate; Hydrochlorothiazide; Valsartan Patents
Given below is the list of patents protecting Amlodipine Besylate; Hydrochlorothiazide; Valsartan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Exforge Hct |
US8475839 (Pediatric) | Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
Nov 16, 2023
(Expired) | Novartis |
| Exforge Hct | US8101599 | Pharmaceutical composition containing anti-hypertensive agents |
May 16, 2023
(Expired) | Novartis |
| Exforge Hct | US8475839 | Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
May 16, 2023
(Expired) | Novartis |
| Exforge Hct |
US6294197 (Pediatric) | Solid oral dosage forms of valsartan |
Dec 18, 2017
(Expired) | Novartis |
| Exforge Hct | US6294197 | Solid oral dosage forms of valsartan |
Jun 18, 2017
(Expired) | Novartis |
| Exforge Hct |
US5399578 (Pediatric) | Acyl compounds |
Sep 21, 2012
(Expired) | Novartis |
Amlodipine Besylate; Hydrochlorothiazide; Valsartan's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List